You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 110 No. 7, July 1975 TABLE OF CONTENTS
  Archives
  •  Online Features
  A PANEL BY CORRESPONDENCE
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (8)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Carcinoma of the Thyroid

Jerome J. DeCosse, MD; William H. Beierwaltes, MD; John R. Brooks, MD; Colin G. Thomas, Jr., MD; Lewis B. Woolner, MD

Arch Surg. 1975;110(7):783-789.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

DR. DECOSSE: During the past ten to 20 years, there has been a notable evolution in the diagnosis and management of the more differentiated forms of carcinoma of the thyroid. No single contribution stands out as having redirected the course of therapy of patients with these tumors, but, from many different studies, gradual trends have emerged.

It now seems accepted by all that patients with papillary and follicular carcinoma of the thyroid may indeed die of cancer if they are observed long enough. Therefore, prompt and aggressive management is worthwhile. Patients may ultimately die of residual or recurrent papillary carcinoma, and, in some instances, these more favorable tumors will undergo metaplasia to lethal spindle cell and anaplastic carcinoma.

Despite unanimity about the risks of these more differentiated forms of thyroid cancer, there is considerable lack of uniformity regarding diagnosis and management. It is the purpose of this panel to establish . . . [Full Text PDF of this Article]


Footnotes

Accepted for publication Jan 14, 1975.

Members of the panel: Jerome J. DeCosse, MD, Professor, Chairman of Surgery, Medical College of Wisconsin, Milwaukee; William H. Beierwaltes, MD, Professor of Medicine, Physician-in-Charge, Division of Nuclear Medicine, University of Michigan, Ann Arbor; John R. Brooks, MD, Professor of Surgery, Harvard Medical School, Peter Bent Brigham Hospital, Boston; Colin G. Thomas, Jr., MD, Professor, Chairman of Surgery, University of North Carolina, Chapel Hill; Lewis B. Woolner, MD, Professor of Pathology, Mayo Foundation Graduate School, Rochester, Minn.

For this Panel by Correspondence the ARCHIVES asked Dr. DeCosse to solicit the help of four other experts to prepare ten questions and to answer them independently. We are grateful to him for acting as moderator and to all of the panelists for their effort.

Reprint requests to Division of Surgery, Medical College of Wisconsin, 8700 Wisconsin Ave, Milwaukee, WI 53226 (Dr. DeCosse).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1975 American Medical Association. All Rights Reserved.